NeuroLex Laboratories is a seed-stage diagnostics company applying speech analysis to detect various health conditions early, before full-blown symptoms occur. Our core vision is to pioneer a universal voice test, like a blood test with extracted features and reference ranges, for use in primary care to refer patients to specialists faster.
“TMCx is a great asset for us as we grow our research pilot pipeline, secure contracts and draft grant applications,” said Jim Schwoebel, CEO. “The community already has added tremendous value and access to the right people that can help our pilots, contracts and grant applications move faster. We’re very much excited to be a part of the community and hope to see it continue to grow into the future.”